About GenoxInvest
Company Overview
GenoxInvest is a relatively new investment firm, founded on 10 July 2023, and based in China. The company has no disclosed employee count and operates without any verified regulatory license. As a non-regulated entity, it falls outside the oversight of major financial authorities, which may expose traders to risks such as lack of transparency and accountability. The official registration in China suggests a primary focus on Asian markets, but the absence of regulation raises immediate concerns for international traders.
Regulation and Safety
GenoxInvest does not hold any verified regulatory license from any known financial regulator. This means the broker is not subject to the standards, audits, or investor protections enforced by bodies such as the FCA, CySEC, ASIC, or others. In many jurisdictions, dealing with an unregulated broker carries significant risk, as there is no recourse to a compensation scheme or ombudsman in case of disputes. Traders should be aware that without regulation, the broker's practices are not independently monitored, and the safety of funds is solely dependent on the company's internal policies.
Account Types and Minimum Deposit
Details regarding account types, minimum deposit requirements, spreads, leverage, and commissions are not disclosed in available sources. Prospective traders should request this information directly from GenoxInvest before committing any funds. It is common for unregulated brokers to have non-standard terms, and the lack of transparency here is a potential warning sign.
Deposits, Withdrawals, and Funding Methods
The specific methods for depositing and withdrawing funds, such as bank transfers, credit cards, or e-wallets, are not listed in the provided data. There are no reported withdrawal complaints, but this may simply reflect the small number of reviews. Traders should exercise caution and seek clear policies on processing times and fees before depositing any money.
Tradable Instruments and Platforms
The range of tradable instruments (forex, CFDs, cryptocurrencies, etc.) and the trading platform (e.g., MetaTrader 4/5, proprietary) are not disclosed in the available information. This lack of detail makes it difficult for traders to assess whether GenoxInvest meets their trading needs. It is advisable to confirm these aspects with the broker before opening an account.
Fees and Costs
No information on trading fees, spreads, commissions, overnight swaps, or non-trading fees is available. As with other details, traders should obtain a full fee schedule from GenoxInvest to understand the true cost of trading. Unregulated brokers sometimes have hidden fees, so transparency is crucial.
User Reviews and Reputation
The few user reviews available are uniformly negative, with a Trustpilot rating of 2.1/5 from 11 reviews. Two reviewers explicitly call the broker a scam, while another describes aggressive sales tactics: after creating an account, they received calls from ten different numbers over two weeks, pressuring a $250 investment. One reviewer reports a friend losing the same $250 amount. These reports suggest a pattern of high-pressure sales and potential loss, consistent with scam warnings. No positive reviews were found, and the Forex Peace Army rating of 'None' indicates insufficient data for a score.
Final Verdict
Based on the available evidence, GenoxInvest presents a significant risk to traders. The lack of regulation, complete absence of positive user experiences, and multiple scam allegations make it unsuitable for anyone seeking a safe and transparent trading environment. The FXCanary Scam Risk Score of 51/100 (Elevated) reflects these concerns. Traders are strongly advised to avoid depositing funds with GenoxInvest until it obtains credible regulatory oversight and demonstrates a track record of honest, complaint-free operations. For those considering this broker, extreme caution is warranted, and any investment should be considered high-risk.
Overview compiled by FXCanary from regulatory records and public data. full GenoxInvest review